DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Operating Room Homepage

Surgeons should rely on visual interpretations and software for tumor detection, says study May reduce biopsies for prostate tumor removal

NIH awards $3.5 million for development of tumor killing robotic system Operates within MR scanner, uses high-intensity therapeutic ultrasound

FDA clears OpenSight AR System for HoloLens First augmented system for HoloLens, helps with preoperative surgical planning

J. Christopher Barry NuVasive names to succeed Gregory T. Lucier as chief executive officer; Lucier to remain chairman of the board

Surgeons can 'listen' to brain during tumor removal with new technique Can predict likely outcome of removing certain brain tissue

Stryker inks two partnerships for enhanced surgical guidance Offering whole-brain tractography and detail-rich imaging

NuVasive to offer intraoperative neuromonitoring services to Premier clientele Reduces surgical risk for full range of procedures

New tech lets people with spinal cord injuries walk again 'It's amazing what the human body can accomplish with help from research and technology'

Medtronic in $1.6 billion deal for Mazor Robotics 'We believe robotic-assisted procedures are the future of spine surgery'

Johnson & Johnson acquires Emerging Implant Technologies GmbH Company aims to improve spinal fusion technology and outcomes

Merit Medical Systems to acquire
Cianna Medical

Merit Medical Systems to acquire Cianna Medical for $135 million

John R. Fischer , Staff Reporter
Merit Medical Systems Inc. has agreed to acquire Cianna Medical Inc. for an upfront payment of $135 million.

The multi-specialty manufacturer is expected to complete its transaction for the California-based enterprise at the closing of the fourth quarter of 2018, providing its customer base with access to wire-free breast localization tools, including Cianna’s SCOUT and SAVI Brachy technologies.

Story Continues Below Advertisement

Click to visit GE Healthcare Service Shop for ultrasound probe solutions

Get reliable ultrasound probe replacements, faster repair, and service coverage you can count on with GE Healthcare. Service Shop gives customers on-demand access to over 100 OEM new, used, and refurbished probe replacements.



"This transaction adds to Merit a technology leader in breast tumor localization that is precise, highly directional, and visible," said Merit's chairman and chief executive officer Fred P. Lampropoulos, in a statement. "With more than 350 initiations and 45,000 wire-free localizations to date, the SAVI SCOUT is complementary to Merit's strategic biopsy initiatives." Additionally, Merit intends to market the SAVI Brachy, which uses thin tubes to deliver radiation to lumpectomy sites.

A developer of the first nonradioactive, wire-free breast localization system, Cianna is the only manufacturer in the world of technology that utilizes RADAR in human tissue, according to Merit.

Launched in 2015, the SCOUT Radar Localization System enables clinicians to localize tumors a day prior to the surgery, shortening procedure time compared to conventional wired systems. Such a feature has enabled revenues for the device to grow from $1 million at its debut to a projected $29 million in 2018, with its current estimated market share at approximately 5 percent with no revenues currently outside of the U.S.

It also allows surgeons to target affected tissue within +/-1 millimeter of its location, and can be used both for lumpectomy localization and to mark biopsy sites without creating any significant artifacts on MR images.

The SAVI Brachy platform is designed for single-entry ease, with its catheters expanding to fit the size and shape of a tumor cavity, and delivering radiation in the form of interstitial brachytherapy combined with tissue-sparing dosimetry capabilities. Merit, however, will only market the catheter and is not involved in the development, sale or transport of radiation seeds.

The structure of the agreement also includes potential earn-out payments of $15 million for achievement of supply chain and scalability metrics as part of the initial $135 million payment, and up to $50 million more for the achievement of sales milestones.

In addition, Merit plans to maintain all commercial and R&D teams from the Cianna family and to enhance overall coverage as well as logistical and clinical support in areas that are currently underserved by Cianna Medical.
  Pages: 1 - 2 >>

Operating Room Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2018 DOTmed.com, Inc.
版权所有